9-OxonerolidolCAS# 58865-88-6 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 58865-88-6 | SDF | Download SDF |
| PubChem ID | 73331190 | Appearance | Oil |
| Formula | C15H24O2 | M.Wt | 236.4 |
| Type of Compound | Sesquiterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (6E,10S)-10-hydroxy-2,6,10-trimethyldodeca-2,6,11-trien-4-one | ||
| SMILES | CC(=CC(=O)CC(=CCCC(C)(C=C)O)C)C | ||
| Standard InChIKey | NYBCPVODSGRKRC-XETPBLJFSA-N | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
9-Oxonerolidol Dilution Calculator
9-Oxonerolidol Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 4.2301 mL | 21.1506 mL | 42.3012 mL | 84.6024 mL | 105.753 mL |
| 5 mM | 0.846 mL | 4.2301 mL | 8.4602 mL | 16.9205 mL | 21.1506 mL |
| 10 mM | 0.423 mL | 2.1151 mL | 4.2301 mL | 8.4602 mL | 10.5753 mL |
| 50 mM | 0.0846 mL | 0.423 mL | 0.846 mL | 1.692 mL | 2.1151 mL |
| 100 mM | 0.0423 mL | 0.2115 mL | 0.423 mL | 0.846 mL | 1.0575 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Secoxyloganin
Catalog No.:BCN5800
CAS No.:58822-47-2
- [Leu5]-Enkephalin
Catalog No.:BCC5831
CAS No.:58822-25-6
- SB 297006
Catalog No.:BCC6129
CAS No.:58816-69-6
- Toosendanin
Catalog No.:BCN1007
CAS No.:58812-37-6
- Benzalazine
Catalog No.:BCC8843
CAS No.:588-68-1
- KU 55933
Catalog No.:BCC2475
CAS No.:587871-26-9
- ABT 724 trihydrochloride
Catalog No.:BCC7293
CAS No.:587870-77-7
- C7280948
Catalog No.:BCC6443
CAS No.:587850-67-7
- ZCL278
Catalog No.:BCC3665
CAS No.:587841-73-4
- Alpha-Belladonnine
Catalog No.:BCN1894
CAS No.:5878-33-1
- Pinostilbenoside
Catalog No.:BCN5799
CAS No.:58762-96-2
- Haplopine
Catalog No.:BCN3921
CAS No.:5876-17-5
- Ophiopogonanone E
Catalog No.:BCN6625
CAS No.:588706-66-5
- Ophiopogonanone F
Catalog No.:BCN6409
CAS No.:588706-67-6
- Trichostatin A (TSA)
Catalog No.:BCC3605
CAS No.:58880-19-6
- Arjungenin
Catalog No.:BCN8223
CAS No.:58880-25-4
- Nalmefene hydrochloride
Catalog No.:BCC7857
CAS No.:58895-64-0
- Monomyristin
Catalog No.:BCN8388
CAS No.:589-68-4
- Laurolitsine
Catalog No.:BCN2634
CAS No.:5890-18-6
- Cassythicine
Catalog No.:BCN5802
CAS No.:5890-28-8
- Z-Glu-OtBu
Catalog No.:BCC2778
CAS No.:5891-45-2
- D-Phe-Ol
Catalog No.:BCC2580
CAS No.:58917-85-4
- Cyclizine 2HCl
Catalog No.:BCC4518
CAS No.:5897-18-7
- Bestatin
Catalog No.:BCC1221
CAS No.:58970-76-6
Identification of novel Nrf2 activators from Cinnamomum chartophyllum H.W. Li and their potential application of preventing oxidative insults in human lung epithelial cells.[Pubmed:28942193]
Redox Biol. 2018 Apr;14:154-163.
Human lung tissue, directly exposed to the environmental oxidants and toxicants, is apt to be harmed to bring about acute or chronic oxidative insults. The nuclear factor erythroid 2-related factor 2 (Nrf2) represents a central cellular defense mechanism, and is a target for developing agents against oxidative insult-induced human lung diseases. Our previous study found that the EtOH extract of Cinnamomum chartophyllum protected human bronchial epithelial cells against oxidative insults via Nrf2 activation. In this study, a systemic phytochemical investigation of the aerial parts of C. chartophyllum led to the isolation of thirty chemical constituents, which were further evaluated for their Nrf2 inducing potential using NAD(P)H: quinone reductase (QR) assay. Among these purified constituents, a sesquiterpenoid bearing alpha, beta-unsaturated ketone group, 3S-(+)-9-Oxonerolidol (NLD), and a diphenyl sharing phenolic groups, 3, 3', 4, 4'-tetrahydroxydiphenyl (THD) significantly activated Nrf2 and its downstream genes, NAD(P)H quinone oxidoreductase 1 (NQO-1), and gamma-glutamyl cysteine synthetase (gamma-GCS), and enhanced the nuclear translocation and stabilization of Nrf2 in human lung epithelial cells. Importantly, NLD and THD had no toxicities under the Nrf2 inducing doses. THD also demonstrated a potential of interrupting Nrf2-Keap1 protein-protein interaction (PPI). Furthermore, NLD and THD protected human lung epithelial cells against sodium arsenite [As(III)]-induced cytotoxicity. Taken together, we conclude that NLD and THD are two novel Nrf2 activators with potential application of preventing acute and chronic oxidative insults in human lung tissue.
